GKB Ophthalmics will close its Register of Members and Share Transfer Books from Wednesday, August 19, 2026 to Tuesday, August 25, 2026, to finalize the list of shareholders eligible for its 44th Annual General Meeting (AGM). The meeting is scheduled for Tuesday, August 25, 2026. The company also disclosed that no dividend is proposed for the financial year 2025-26, signaling a focus on retaining capital rather than distributing profits to shareholders during this period.

The book closure period was notified pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It also complies with Section 91 of the Companies Act, 2013, read with Rule 10 of the Companies (Management and Administration) Rules, 2014. These regulatory frameworks mandate specific timelines for closing share transfer books to ensure an accurate record of ownership before major corporate events like general meetings.

Key Dates and Details

Shareholders holding units as of the end of business on August 18, 2026, will be eligible to participate in the AGM. During the closure period, no transfer of shares or registration of new members will be processed. Investors looking to trade shares should be aware that transactions executed during the closure window will not confer voting rights or eligibility for the upcoming meeting.

Dividend Policy Implications

The decision not to propose a dividend for FY25-26 may reflect the company’s current capital allocation strategy. By withholding dividends, GKB Ophthalmics can retain earnings to fund operational requirements, potential expansion projects, or debt reduction. This approach is often adopted by companies prioritizing growth or stability over immediate shareholder returns. The absence of a dividend payout does not necessarily indicate poor performance but rather a strategic choice regarding cash flow management.

The notice was issued by Pooja Dessai, Company Secretary, on July 31, 2026, and submitted to the Department of Corporate Services at BSE Limited. The communication ensures that all listed stakeholders are informed of the procedural timeline well in advance of the AGM date.

GKB Ophthalmics Ltd received a Notice of Demand from the Office of the Mamlatdar of Bardez Taluka, Mapusa, Goa on July 13, 2026, requiring the payment of Rs 8.82 Cr within 10 days. This demand arises from an order passed by the Labour Commissioner on September 04, 2025, for the recovery of funds from the company. The company intends to challenge the order before the Hon'ble High Court of Bombay by filing a writ petition seeking appropriate relief.

The development is related to ongoing litigation concerning an award passed by the Industrial Tribunal Panjim-Goa on May 25, 2021. The company is currently challenging this award through writ petition no. WP/358/2021 before the Hon'ble High Court of Bombay at Goa. Simultaneously, the matter was pending execution before the Labour Commissioner, leading to the recovery order and the subsequent demand notice.

The disclosure was made to BSE Limited pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation references SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

Details of the Demand

The notice specifies a recovery amount of Rs 8.82 Cr and sets a strict deadline for payment. The company has clarified that it will consult with its legal counsel to contest the demand.

Legal Proceedings

The company is actively involved in legal proceedings regarding the original award by the Industrial Tribunal. The filing of a new writ petition to challenge the recovery order represents the latest step in its legal strategy to manage the financial and operational implications of the case.